{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:29:40Z","timestamp":1791948580214,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T00:00:00Z","timestamp":1643932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.dadr.2022.100031","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T13:20:00Z","timestamp":1644240000000},"page":"100031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3564-9139","authenticated-orcid":false,"given":"Courtney D.","family":"Nordeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon Gwin","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"O'Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gryczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2022.100031_bib0001","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13311-019-00814-4","article-title":"Availability of medications for the treatment of alcohol and opioid use disorder in the USA","volume":"17","author":"Abraham","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.dadr.2022.100031_bib0002","series-title":"Provisional Drug Overdose Death Counts","author":"Ahmad","year":"2021"},{"key":"10.1016\/j.dadr.2022.100031_bib0003","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaac.2010.10.005","article-title":"Disparities in treatment for substance use disorders and co-occurring disorders for ethnic\/racial minority youth","volume":"50","author":"Alegria","year":"2011","journal-title":"J. Am. Acad. Child Adolesc."},{"key":"10.1016\/j.dadr.2022.100031_bib0004","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1377\/hlthaff.2020.02261","article-title":"Addressing racial and ethnic disparities in the use of medications for opioid use disorder: Study examines racial and ethnic disparities in the use of medications for opioid use disorder","volume":"40","author":"Andraka-Christou","year":"2021","journal-title":"Health Aff."},{"key":"10.1016\/j.dadr.2022.100031_bib0005","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11606-017-3993-2","article-title":"Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention","volume":"32","author":"D'Onofrio","year":"2017","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0006","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1007\/s11606-019-05251-9","article-title":"Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis","volume":"34","author":"Englander","year":"2019","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0007","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000611","article-title":"Predictors of opioid and alcohol pharmacotherapy initiation at hospital discharge among patients seen by an inpatient addiction consult service","author":"Englander","year":"2020","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0008","doi-asserted-by":"crossref","first-page":"339","DOI":"10.12788\/jhm.2736","article-title":"Planning and designing the improving addiction care team (IMPACT) for hospitalized adults with substance use disorder","volume":"12","author":"Englander","year":"2017","journal-title":"J. Hosp. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0009","doi-asserted-by":"crossref","DOI":"10.7326\/M20-5475","article-title":"Preventing hospital readmission for patients with comorbid substance use disorder","author":"Gryczynski","year":"2021","journal-title":"A Randomized Trial. Ann. Intern. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.mcna.2020.03.003","article-title":"Diagnosis and management of opioid use disorder in hospitalized patients","volume":"104","author":"Herscher","year":"2020","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.dadr.2022.100031_bib0011","article-title":"Trust in hospital physicians among patients with substance use disorder referred to an addiction consult service: a mixed-methods study","author":"King","year":"2021","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0012","article-title":"Causes of death in the 12\u200amonths after hospital discharge among patients with opioid use disorder","author":"King","year":"2021","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108121","article-title":"Patterns of substance use before and after hospitalization among patients seen by an inpatient addiction consult service: a latent transition analysis","volume":"118","author":"King","year":"2020","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.dadr.2022.100031_bib0014","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","article-title":"Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial","volume":"174","author":"Liebschutz","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis","volume":"345","author":"MacArthur","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.dadr.2022.100031_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108435","article-title":"Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: a cohort study","volume":"219","author":"Macmadu","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2022.100031_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.dadr.2022.100031_bib0018","first-page":"256","article-title":"A substance abuse consultation service: enhancing the care of hospitalized substance abusers and providing training in addiction psychiatry","volume":"6","author":"McDuff","year":"1997","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.dadr.2022.100031_bib0019","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cpr.2017.10.012","article-title":"Sex and gender differences in substance use disorders","volume":"66","author":"McHugh","year":"2018","journal-title":"Clin. Psychol. Rev"},{"key":"10.1016\/j.dadr.2022.100031_bib0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2016.07.004","article-title":"Post-discharge treatment engagement among patients with an opioid-use disorder","volume":"69","author":"Naeger","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.dadr.2022.100031_bib0021","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13722-016-0065-6","article-title":"Alcohol use in opioid agonist treatment","volume":"11","author":"Nolan","year":"2016","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.dadr.2022.100031_bib0022","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2017.12.043","article-title":"Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation-liaison service","volume":"186","author":"Nordeck","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2022.100031_bib0023","first-page":"5","article-title":"Navigation services to avoid rehospitalization among medical\/surgical patients with comorbid substance use disorder: rationale and design of a randomized controlled trial","author":"Nordeck","year":"2020","journal-title":"J. Psychiatry Brain Sci."},{"key":"10.1016\/j.dadr.2022.100031_bib0024","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/00952990701523698","article-title":"Quality of life among heroin users on buprenorphine versus methadone maintenance","volume":"33","author":"Ponizovsky","year":"2007","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.dadr.2022.100031_bib0025","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s11606-020-05815-0","article-title":"Opioid agonist therapy during hospitalization within the veterans health administration: a pragmatic retrospective cohort analysis","volume":"35","author":"Priest","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0026","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/ADM.0000000000000496","article-title":"The role of the hospital in the 21st century opioid overdose epidemic: the addiction medicine consult service","volume":"13","author":"Priest","year":"2019","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsat.2015.09.006","article-title":"Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review","volume":"61","author":"Priester","year":"2016","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.dadr.2022.100031_bib0028","article-title":"Emergency department-initiated buprenorphine and referral to follow-up addiction care: a program description","author":"Regan","year":"2021","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0029","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","article-title":"Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002\u201312","volume":"35","author":"Ronan","year":"2016","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.dadr.2022.100031_bib0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.amjmed.2015.09.024","article-title":"Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis","volume":"129","author":"Rosenthal","year":"2016","journal-title":"Am. J. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0031","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11606-010-1311-3","article-title":"A transitional opioid program to engage hospitalized drug users","volume":"25","author":"Shanahan","year":"2010","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0032","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11920-017-0783-9","article-title":"Update on barriers to pharmacotherapy for opioid use disorders","volume":"19","author":"Sharma","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.dadr.2022.100031_bib0033","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.dadr.2022.100031_bib0034","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000363232","article-title":"Alcohol use disorders in opioid maintenance therapy: prevalence, clinical correlates and treatment","volume":"21","author":"Soyka","year":"2015","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.dadr.2022.100031_bib0035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/10911351003673310","article-title":"Barriers to treatment for women with substance use disorders","volume":"20","author":"Taylor","year":"2010","journal-title":"J. Hum. Behav. Soc. Environ."},{"key":"10.1016\/j.dadr.2022.100031_bib0036","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jama.2021.7374","article-title":"Use of medications for treatment of opioid use disorder among us medicaid enrollees in 11 states, 2014-2018","volume":"326","author":"Brown","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.dadr.2022.100031_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2017.05.007","article-title":"Addiction consultation services \u2013 linking hospitalized patients to outpatient addiction treatment","volume":"79","author":"Trowbridge","year":"2017","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.dadr.2022.100031_bib0038","article-title":"Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl","author":"Varshneya","year":"2021","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0039","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s11606-016-3919-4","article-title":"It's been an experience, a life learning experience\u201d: a qualitative study of hospitalized patients with substance use disorders","volume":"32","author":"Velez","year":"2017","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(17)32893-3","article-title":"Medications for opioid use disorder: bridging the gap in care","volume":"391","author":"Volkow","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.dadr.2022.100031_bib0041","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies \u2014 tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0042","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2022.100031_bib0043","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11606-017-4077-z","article-title":"Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity","volume":"32","author":"Wakeman","year":"2017","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.dadr.2022.100031_bib0044","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/08897077.2016.1187240","article-title":"Attitudes, practices, and preparedness to care for patients with substance use disorder: results from a survey of general internists","volume":"37","author":"Wakeman","year":"2016","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.dadr.2022.100031_bib0045","first-page":"587","article-title":"Inpatient addiction consult service: expertise for hospitalized patients with complex addiction problems","volume":"102","author":"Weinstein","year":"2018","journal-title":"Med. Clin."},{"key":"10.1016\/j.dadr.2022.100031_bib0046","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/QAI.0000000000000165","article-title":"HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial","volume":"66","author":"Woody","year":"2014","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.dadr.2022.100031_bib0047","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofw157","article-title":"Increasing infectious endocarditis admissions among young people who inject drugs","volume":"3","author":"Wurcel","year":"2016","journal-title":"Open Forum Infect. Dis."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724622000099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724622000099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:32:39Z","timestamp":1757421159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724622000099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":47,"alternative-id":["S2772724622000099"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2022.100031","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2022.100031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100031"}}